We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$716M
AUM Growth
-$19.1M
Cap. Flow
+$8.71M
Cap. Flow %
1.22%
Top 10 Hldgs %
27.06%
Holding
107
New
3
Increased
17
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$11.4M
2
VCYT icon
Veracyte
VCYT
+$10M
3
LOW icon
Lowe's Companies
LOW
+$3.19M
4
CPN
Calpine Corporation
CPN
+$2.73M
5
LYB icon
LyondellBasell Industries
LYB
+$2.16M

Top Sells

Rank Stock Value
1
ROC
ROCKWOOD HLDGS INC
ROC
+$12.9M
2
SDRL
Seadrill Limited Common Stock
SDRL
+$9.17M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.54M
4
UFS
DOMTAR CORPORATION (New)
UFS
+$2.29M
5
SZYM
SOLAZYME INC COM STK (DE)
SZYM
+$1.82M

Sector Composition

Rank Sector Weight
1 Healthcare 29.21%
2 Technology 14.59%
3 Consumer Discretionary 13.52%
4 Industrials 8.55%
5 Energy 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
101
uniQure
QURE
$2.93B
$452K 0.06%
49,100
+27,634
+129% +$303K
RPTP
102
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$387K 0.05%
40,400
– –
VSTM icon
103
Verastem
VSTM
$536M
$178K 0.02%
1,742
– –
ARAV
104
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-8,333
Closed -$1.4M
SDRL
105
DELISTED
Seadrill Limited Common Stock
SDRL
– –
-857
Closed -$9.17M
ROC
106
DELISTED
ROCKWOOD HLDGS INC
ROC
– –
-170,400
Closed -$12.9M
AMBI
107
DELISTED
Ambit Biosciences Corp
AMBI
– –
-151,100
Closed -$1.04M
1 2 3 4
5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, Eventide Asset Management held 107 positions worth $716M, down 2.6% from $735M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management's Q3 2014 filing shows 3 new, 17 increased, 4 reduced and 4 closed positions. Its largest new stake was Sage Therapeutics: 40,200 shares worth $1.27M. The largest sale was ROCKWOOD HLDGS INC, an estimated $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q3 2014 buy was Sage Therapeutics: 40,200 shares worth $1.27M.
  • Eventide Asset Management added most to bluebird bio in Q3 2014, an estimated $11.4M increase.
  • Eventide Asset Management's biggest Q3 2014 reduction was Agios Pharmaceuticals, cutting an estimated $2.54M.
  • Eventide Asset Management fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $12.9M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $716M portfolio in Q3 2014.
  • Eventide Asset Management opened 3 new positions and closed 4 in Q3 2014.
  • Eventide Asset Management's portfolio value fell 2.6% quarter-over-quarter to $716M.

Based on Eventide Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.